Ifi27l2a identified as new therapeutic target to reduce brain injury in stroke
Feb. 23, 2023
Microglial cells (MGs) are resident immune cells in the brain, which play a key role in the acute response and chronic recovery to stroke. Investigators at the University of Texas Health Science Center Houston aimed to evaluate MG transcriptomic response to stroke in mouse brain.